文献速递中药与中成药合理使用

酸枣仁及其成方制剂质量控制研究进展

Research progress of quality control for the seed of Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F. Chow (Suan-Zao-Ren) and its proprietary Chinese medicines.
PubMed 文献 · J Ethnopharmacol · 2023-01-28

该综述系统梳理了酸枣仁及其成方制剂的质量控制研究,涉及活性成分、Q-Marker、检测方法及全生产流程质量传递规律,指出酸枣仁苷A、酸枣仁苷B和斯皮诺素为关键Q-Marker,高效液相色谱-紫外/蒸发光散射检测和指纹图谱分析为主流质控方法,基于单位含量的质量评价新方法已应用于酸枣仁及其成方制剂。

要点

  • 酸枣仁苷A、酸枣仁苷B和斯皮诺素为酸枣仁关键Q-Marker。
  • 高效液相色谱-紫外/蒸发光散射检测和指纹图谱分析为主流质控方法。
  • 破碎和配伍是影响酸枣仁活性成分的关键环节。

核心结论

  • 酸枣仁苷A、酸枣仁苷B和斯皮诺素被揭示为酸枣仁的关键Q-Marker。
  • 基于单位含量的质量评价新方法已应用于酸枣仁及其成方制剂。
  • 破碎和配伍是影响酸枣仁活性成分的关键步骤。

研究设计与样本

  • 检索数据库包括PubMed、CNKI、Google Scholar和Web of Science等。

主要发现

  • Q-Marker含量存在显著波动。
  • 基于全生产流程阐明了Q-Marker的质量传递规律,涉及产地、成熟时间、初加工、炮制、配伍煎煮/提取和贮藏。

关键数值与推荐

  • 高效液相色谱-紫外/蒸发光散射检测和指纹图谱分析为酸枣仁质控主流方法。
  • Q-Marker为酸枣仁苷A、酸枣仁苷B和斯皮诺素。

临床怎么用

  • 可将酸枣仁苷A、酸枣仁苷B和斯皮诺素作为酸枣仁及其成方制剂的质量控制指标。
  • 质控应关注破碎和配伍等关键生产环节对活性成分的影响。

局限性

  • 许多商品酸枣仁产品难以用现行方法合格判定。
  • 酸枣仁成方制剂的质量标准稀缺。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Semen Ziziphi Spinosae (SZS), the seed of Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F. Chow (Chinese name Suan-Zao-Ren), is widely distributed in China, Laos, Myanmar, and Iran. It is a classic traditional Chinese medicine with sedative and sleeping effects. In clinical practice, there are more than 155 proprietary Chinese medicines containing SZS. However, many commercial SZS products are difficult to qualify using current methods. Moreover, there is a scarcity of quality standards for SZS in proprietary Chinese medicines. AIM OF THE STUDY: The purpose of this study was to clearly reveal the quality indicators during the entire production process of SZS and its products. MATERIALS AND METHODS: This study reviewed more than 230 articles and related books on the quality control of SZS and its proprietary Chinese medicines published over the last 40 years (from January 1979 to October 2022). Moreover, where available, information on the quality of SZS and its proprietary Chinese medicines was also collected from websites for comparison, including online publications (e.g. PubMed, CNKI, Google Scholar, and Web of Science), the information at Yaozhi website and China Medical Information Platform, along with some classic books on Chinese herbal medicine. The literature and information search were conducted using keywords such as "Suan-Zao-Ren", " Ziziphus jujuba" and "quality control", and the latest results from various databases were combined to obtain valid information. The active components, which in vivo exposure, and Q-markers were also summarized. RESULTS: The jujuboside A, jujuboside B, and spinosin were revealed as the key Q-markers for SZS. Moreover, the advancements and prospects of the quality control for SZS and its extract, proprietary Chinese medicines, health foods, and adulterants were comprehensively summarized. The high-performance liquid chromatography-UV/evaporative light scattering detection and fingerprint analysis were found to be the mainstream methods for the SZS quality control. In particular, the novel quality evaluation method based on the unit content was applied for SZS and its proprietary Chinese medicines. Significant fluctuations were found in the contents of Q-markers. Moreover, the mass transfer rule of Q-markers was comprehensively clarified based on the entire production process, including production origins, ripening time, primary process, processing, compatibility decoction/extract, and storage. Ultimately, the crushing and compatibility of SZS were found to be the key steps affecting the active components. CONCLUSIONS: In short, this study provides solid evidences to reveal quality indicators for the entire production process of developing rational quality standards for SZS and its products. Moreover, this study also provides a template quality control overview, which could be extended to other traditional Chinese medicines.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Gong L, Xie JB, Luo Y, et al. Research progress of quality control for the seed of Ziziphus jujuba var. spinosa (Bunge) Hu ex H.F. Chow (Suan-Zao-Ren) and its proprietary Chinese medicines. J Ethnopharmacol. 2023. PMID: 36720435. doi:10.1016/j.jep.2023.116204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。